TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$325 Million

BioCryst Pharmaceuticals

Sole Placement Agent, December 2020

More Like This

Mar 2024

Exchange of all Outstanding Series B Convertible Preferred Stock for Common Stock

Financial Advisor

View Details >
Mar 2024
$600 Million

Follow-on Offering

Bookrunner

View Details >
Mar 2024
$150 Million

Underwritten Offering

Lead Left Bookrunner

View Details >